» Articles » PMID: 28754671

Src Inhibits the Hippo Tumor Suppressor Pathway Through Tyrosine Phosphorylation of Lats1

Overview
Journal Cancer Res
Specialty Oncology
Date 2017 Jul 30
PMID 28754671
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

The Hippo pathway regulates cell proliferation, apoptosis, and stem cell self-renewal, and its inactivation in animal models causes organ enlargement followed by tumorigenesis. Hippo pathway deregulation occurs in many human cancers, but the underlying mechanisms are not fully understood. Here, we report tyrosine phosphorylation of the Hippo pathway tumor suppressor LATS1 as a mechanism underlying its regulation by cell adhesion. A tyrosine kinase library screen identified Src as the kinase to directly phosphorylate LATS1 on multiple residues, causing attenuated Mob kinase activator binding and structural alteration of the substrate-binding pocket in the kinase domain. Cell matrix adhesion activated the Hippo pathway effector transcription coactivator YAP partially through Src-mediated phosphorylation and inhibition of LATS1. Aberrant Src activation abolished the tumor suppressor activity of LATS1 and induced tumorigenesis in a YAP-dependent manner. Protein levels of Src in human breast cancer tissues correlated with accumulation of active YAP dephosphorylated on the LATS1 target site. These findings reveal tyrosine phosphorylation of LATS1 by Src as a novel mechanism of Hippo pathway regulation by cell adhesion and suggest Src activation as an underlying reason for YAP deregulation in tumorigenesis. .

Citing Articles

The IGF2BP1 oncogene is a druggable mA-dependent enhancer of YAP1-driven gene expression in ovarian cancer.

Schott A, Simon T, Muller S, Rausch A, Busch B, Glass M NAR Cancer. 2025; 7(1):zcaf006.

PMID: 40008228 PMC: 11850222. DOI: 10.1093/narcan/zcaf006.


A highly sensitive reporter system to monitor endogenous YAP1/TAZ activity and its application in various human cells.

Hikasa H, Kawahara K, Inui M, Yasuki Y, Yamashita K, Otsubo K Cancer Sci. 2024; 115(10):3370-3383.

PMID: 39155534 PMC: 11447953. DOI: 10.1111/cas.16316.


Crk mediates Csk-Hippo signaling independently of Yap tyrosine phosphorylation to induce cell extrusion.

Hannan A, Wang Q, Wu Y, Makrides N, Qu X, Mao J bioRxiv. 2024; .

PMID: 39005335 PMC: 11244872. DOI: 10.1101/2024.06.27.601065.


Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer.

Sarmasti Emami S, Ge A, Zhang D, Hao Y, Ling M, Rubino R Int J Mol Sci. 2024; 25(7).

PMID: 38612874 PMC: 11012486. DOI: 10.3390/ijms25074064.


HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14.

Blakely W, Hatterschide J, White E bioRxiv. 2024; .

PMID: 38496413 PMC: 10942435. DOI: 10.1101/2024.03.07.583953.